These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 28866868
1. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma. Cai L, Lv J, Zhang Y, Li J, Wang Y, Yang H. J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868 [Abstract] [Full Text] [Related]
2. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma. Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J. J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852 [Abstract] [Full Text] [Related]
3. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X, Xiong Y, Tang F, Bian Y, Chen Y, Zhang F. Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [Abstract] [Full Text] [Related]
4. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB, Wang JA, Lv RQ. Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [Abstract] [Full Text] [Related]
5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y, Feng D, Gu X, Gao A, Liu Y. Anticancer Drugs; 2021 Feb 01; 32(2):168-177. PubMed ID: 32826416 [Abstract] [Full Text] [Related]
6. CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. Luo Y, Tao H, Jin L, Xiang W, Guo W. Cancer Biother Radiopharm; 2020 Feb 01; 35(1):58-65. PubMed ID: 31724892 [Abstract] [Full Text] [Related]
7. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. Ye H, Lin J, Yao X, Li Y, Lin X, Lu H. Cell Physiol Biochem; 2018 Feb 01; 45(5):1904-1914. PubMed ID: 29518771 [Abstract] [Full Text] [Related]
8. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Ma B, Li M, Zhang L, Huang M, Lei JB, Fu GH, Liu CX, Lai QW, Chen QQ, Wang YL. Tumour Biol; 2016 Apr 01; 37(4):4445-55. PubMed ID: 26499949 [Abstract] [Full Text] [Related]
9. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma. Chen S, Li W, Guo A. Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30944201 [Abstract] [Full Text] [Related]
10. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma. Zhang Y, Meng W, Cui H. Biomed Pharmacother; 2018 Jun 30; 102():169-174. PubMed ID: 29554595 [Abstract] [Full Text] [Related]
11. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y. Oncotarget; 2015 Apr 20; 6(11):9160-72. PubMed ID: 25863539 [Abstract] [Full Text] [Related]
12. TCF-3-mediated transcription of lncRNA HNF1A-AS1 targeting oncostatin M expression inhibits epithelial-mesenchymal transition via TGFβ signaling in gastroenteropancreatic neuroendocrine neoplasms. Xue J, Bai J, Long Q, Wei Y, Pan J, Li X, Tang Q. Aging (Albany NY); 2021 May 25; 13(10):14065-14077. PubMed ID: 34037532 [Abstract] [Full Text] [Related]
13. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis. Lou P, Ding T, Zhan X. Cancer Biother Radiopharm; 2021 May 25; 36(4):371-381. PubMed ID: 32706998 [Abstract] [Full Text] [Related]
14. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5. Hu XH, Dai J, Shang HL, Zhao ZX, Hao YD. Biochem Biophys Res Commun; 2019 Apr 09; 511(3):510-517. PubMed ID: 30819403 [Abstract] [Full Text] [Related]
15. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin CZ, Qu Q, Wang GH, He CJ, Zhou HH. Int J Mol Sci; 2016 Aug 30; 17(9):. PubMed ID: 27589728 [Abstract] [Full Text] [Related]
16. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression. He JW, Li DJ, Zhou JH, Zhu YL, Yu BQ. Biochem Biophys Res Commun; 2020 Jun 04; 526(3):670-677. PubMed ID: 32248969 [Abstract] [Full Text] [Related]
17. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Wang F, Ni H, Sun F, Li M, Chen L. Biomed Pharmacother; 2016 Jul 04; 81():152-159. PubMed ID: 27261589 [Abstract] [Full Text] [Related]
18. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W, Zhang E, Song L, Tu L, Wang Z, Tian F, Aikenmu K, Chu G, Zhao J. Biomed Pharmacother; 2018 Oct 04; 106():890-895. PubMed ID: 30119259 [Abstract] [Full Text] [Related]
19. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Liu Z, Li H, Fan S, Lin H, Lian W. Cancer Biol Ther; 2019 Oct 04; 20(4):444-453. PubMed ID: 30404566 [Abstract] [Full Text] [Related]
20. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F, Qing X, Liu J, Zhang Z, Shao Z. J Exp Clin Cancer Res; 2019 Aug 23; 38(1):375. PubMed ID: 31443665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]